Health Care: The Next Wave of Innovation in China (Franklin Templeton)
Franklin Templeton’s Emerging Markets Equity team’s Michael Lai and Elizabeth Wu take a look at a new breed of innovative enterprises in China that could transform health care outcomes in the years ahead. READ MORE
Similar Posts:
- Chinese New Year: How Investors Might Navigate Markets in the Year of the Ox (Franklin Templeton)
- China: Innovation Superpower (Wellington Management)
- Templeton’s Chow: “No Reason the Goat and the Bull Cannot be Friends” (Mobius Blog)
- South Korea: A Shining Example of Emerging Market Leadership (Franklin Templeton)
- The Race to Harness AI Technology in Asia (Franklin Templeton)
- The New Emerging Markets Landscape: Policy Improvements Should Contribute to Increased Resilience (Franklin Templeton)
- China: From Smokestack to Labtech (William Blair)
- Investor Sentiment Survey: What Emerging Market Investors Think (Franklin Templeton)
- Today’s Emerging Markets Embrace Technological Innovation (Franklin Templeton Investments)
- China’s Local Equity Market: ‘…How and Where and Who’ (Aberdeen Standard)
Leave a Reply